Immunocore Holdings plc (IMCR) Misses Q2 EPS by 6c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q2 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $60.7 million versus the consensus estimate of $43.81 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c